First Trust Nasdaq Pharmaceuticals ETF · $1.2B$17,719
FTXHFTXH vsIBBIBBiShares Biotechnology ETF · $11.0B$13,555
$10,000 five years ago, dividends reinvested · they hold 36.1% in common
FTXHMeasureIBB
Returns · dividends reinvested
+32.4%Year to dateJan 1 → Nov 6+26.7%
+45.1%1 yearTotal return+35.2%
+23.2%3 years · per year$10,000 became $18,720 · $18,677+23.2%
+12.1%5 years · per year$10,000 became $17,719 · $13,555+6.3%
Cost and income
0.60%Expense ratio$60 · $44 a year on $10k · lower is better0.44%
0.67%Trailing 12-mo yield$67 · $16 a year on $10k0.16%
Risk · past year
−7.5%Worst dropSmaller is better−9.6%
18.3%VolatilityLower is calmer23.4%
FTXHIBB Winner of the row, in its colourEach row: the bigger of the two fills its side
6–1FTXH wins
End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns